News & Views | Published:

Next-gen immunohistochemistry

Nature Methods volume 11, pages 381383 (2014) | Download Citation

  • An Erratum to this article was published on 27 June 2014

This article has been updated

The combination of mass spectroscopy with immunohistochemistry allows highly multiplexed, directly quantitative imaging of tissue samples for both basic and clinical research.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 23 May 2014

    In the version of this article initially published, the surname of the first author of ref. 1 was misspelled as "Geisen"; the correct spelling is "Giesen." The error has been corrected in the HTML and PDF versions of the article.

References

  1. 1.

    et al. Nat. Methods 11, 417–422 (2014).

  2. 2.

    et al. Nat. Med. (2 March 2014).

  3. 3.

    , & Appl. Immunohistochem. Mol. Morphol. 9, 107–116 (2001).

  4. 4.

    , & Nat. Med. 8, 1323–1327 (2002).

  5. 5.

    et al. Proc. Natl. Acad. Sci. USA 110, 11982–11987 (2013).

  6. 6.

    et al. Science 332, 687–696 (2011).

  7. 7.

    et al. Biotechniques 48, 197–209 (2010).

  8. 8.

    et al. Arch. Pathol. Lab. Med. (12 August 2013).

  9. 9.

    & Nature 483, 531–533 (2012).

  10. 10.

    et al. Lab. Invest. (17 February 2014).

Download references

Author information

Affiliations

  1. David L. Rimm is in the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.

    • David L Rimm

Authors

  1. Search for David L Rimm in:

Competing interests

D.L.R. is a scientific cofounder and stockholder in Metamark Genetics, Inc.

Corresponding author

Correspondence to David L Rimm.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nmeth.2896

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing